Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
Dengue virus (DENV) is one of the most widespread arboviruses. The four DENV serotypes infect about 400 million people every year, causing 96 million clinical dengue cases, of which approximately 500'000 are severe and potentially life-threatening. The only licensed vaccine has a limited effica...
Main Authors: | Roland Züst, Shi-Hua Li, Xuping Xie, Sumathy Velumani, Melissa Chng, Ying-Xiu Toh, Jing Zou, Hongping Dong, Chao Shan, Jassia Pang, Cheng-Feng Qin, Evan W Newell, Pei-Yong Shi, Katja Fink |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5751980?pdf=render |
Similar Items
-
Correction: Rational Design of a Live Attenuated Dengue Vaccine: 2′--Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques.
by: Roland Züst, et al.
Published: (2013-09-01) -
Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques.
by: Roland Züst, et al.
Published: (2013-01-01) -
Development and evaluation of a tetravalent botulinum vaccine
by: Dan-Yang Shi, et al.
Published: (2022-11-01) -
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
by: Meihui Xu, et al.
Published: (2017-01-01) -
BRIDGING THE IMMUNOGENICITY OF A TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) FROM CHILDREN AND ADOLESCENTS TO ADULTS
by: C. Halim, et al.
Published: (2023-05-01)